Howard B. Gale

Is Frequent CD4 ⁺ T-Lymphocyte Count Monitoring Necessary for Persons With Counts ≥300 Cells/µL and HIV-1 Suppression?: Figure 1.

Howard B. Gale, Steven Gitterman, Heather J. Hoffman et al. · Clinical Infectious Diseases · 2013 · 84 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

True Durability: HIV Virologic Suppression in an Urban Clinic and Implications for Timing of Intensive Adherence Efforts and Viral Load Monitoring

Debra Benator, Angelo Elmi, Manuel de Buenaga Rodríguez et al. · AIDS and Behavior · 2014 · 24 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +14

Comparison of Serial Hepatitis C Virus Detection in Samples Submitted through Serology for Reflex Confirmation versus Samples Directly Submitted for Quantitation

Howard B. Gale, D. Robert Dufour, Nazia Qazi et al. · Journal of Clinical Microbiology · 2011 · 20 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15

Performance of the TruGene Human Immunodeficiency Virus Type 1 Genotyping Kit and OpenGene DNA Sequencing System on Clinical Samples Diluted to Approximately 100 Copies per Milliliter

Howard B. Gale, Virginia L. Kan, Rebecca C. Shinol · Clinical and Vaccine Immunology · 2006 · 19 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Performance of the Abbott RealTime HCV Genotype II RUO Assay

Rebecca C. Shinol, Howard B. Gale, Virginia L. Kan · Journal of Clinical Microbiology · 2012 · 18 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13